Rentokil hit by N.America woes; no immediate re-listing plans
2024 N.America organic revenue growth seen at lower end of range
No immediate plans to move listing to US
Shares fell as much as 7%
Rewrites, adds share milestones
By Yamini Kalia
July 25 (Reuters) -British pest control company Rentokil Initial RTO.L said on Thursday it expected underlying revenue at its North American business - the group's largest - to come in at the lower end of its forecast, sending its shares as much as 7% lower.
The company, which made about 60% of its revenue in North America last year, also said it had no immediate plans to move its listing to the United States, as some analysts had speculated.
"Going forward, the board will continue to keep the Group's listing structure under review to ensure that the strength of the Group's underlying financial performance and its prospects are appropriately valued," it said in a statement.
Rentokil's shares have fallen about 20% since it flagged softer demand in North America last October.
Earlier this month, the shares rose on reports ex-BT chief Philip Jansen was looking to buy the firm. They also jumped in June on news that activist investor Nelson Peltz's Trian Fund Management had built a stake in the company and was interested in discussing "ideas and initiatives".
In March, Rentokil said it expected organic revenue in North America to rise by 2-4% this year. On Thursday, it said it now expected revenue growth there at the lower end of this range.
For the second quarter, the key North American pest control business posted a 0.5% rise in organic revenue, compared with the previous quarter.
"Investors are ostensibly reacting to the muted quarter-on-quarter improvement in organic growth for the beleaguered North America pest control business," said Morningstar analyst Grant Slade.
Rentokil and rival Rollins ROL.N account for roughly half of the U.S. pest control market, with Rentokil the larger player after it bought U.S. rival Terminix.
Rollins posted a 7.7% organic revenue growth in the second quarter.
"Relative to the growth of the broader market, Rentokil is underperforming the peers while Rollins continues to outperform," Slade added.
Reporting by Yamini Kalia in Bengaluru; Editing by Sherry Jacob-Phillips and Mark Potter
Aset Terkait
Berita Terbaru
Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.
Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.
Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.
